MX9202507A - Composicion farmaceutica para el tratamiento de esofagitis de reflujo. - Google Patents
Composicion farmaceutica para el tratamiento de esofagitis de reflujo.Info
- Publication number
- MX9202507A MX9202507A MX9202507A MX9202507A MX9202507A MX 9202507 A MX9202507 A MX 9202507A MX 9202507 A MX9202507 A MX 9202507A MX 9202507 A MX9202507 A MX 9202507A MX 9202507 A MX9202507 A MX 9202507A
- Authority
- MX
- Mexico
- Prior art keywords
- treatment
- pharmaceutical composition
- reflux esophagitis
- esophagitis
- reflux
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70614591A | 1991-05-28 | 1991-05-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9202507A true MX9202507A (es) | 1992-11-01 |
Family
ID=24836392
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9202507A MX9202507A (es) | 1991-05-28 | 1992-05-27 | Composicion farmaceutica para el tratamiento de esofagitis de reflujo. |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0516345A1 (es) |
JP (1) | JPH05148142A (es) |
KR (1) | KR920021144A (es) |
AU (1) | AU1721892A (es) |
CA (1) | CA2069162A1 (es) |
HU (1) | HU9201751D0 (es) |
MX (1) | MX9202507A (es) |
NO (1) | NO922019L (es) |
TW (1) | TW202387B (es) |
ZA (1) | ZA923711B (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8071128B2 (en) | 1996-06-14 | 2011-12-06 | Kyowa Hakko Kirin Co., Ltd. | Intrabuccally rapidly disintegrating tablet and a production method of the tablets |
US9358214B2 (en) | 2001-10-04 | 2016-06-07 | Adare Pharmaceuticals, Inc. | Timed, sustained release systems for propranolol |
US8367111B2 (en) | 2002-12-31 | 2013-02-05 | Aptalis Pharmatech, Inc. | Extended release dosage forms of propranolol hydrochloride |
US8747895B2 (en) | 2004-09-13 | 2014-06-10 | Aptalis Pharmatech, Inc. | Orally disintegrating tablets of atomoxetine |
US9884014B2 (en) | 2004-10-12 | 2018-02-06 | Adare Pharmaceuticals, Inc. | Taste-masked pharmaceutical compositions |
CA2584957C (en) | 2004-10-21 | 2015-08-25 | Eurand Pharmaceuticals Limited | Taste-masked pharmaceutical compositions with gastrosoluble pore-formers |
US9161918B2 (en) | 2005-05-02 | 2015-10-20 | Adare Pharmaceuticals, Inc. | Timed, pulsatile release systems |
WO2009064458A2 (en) * | 2007-11-13 | 2009-05-22 | Meritage Pharma, Inc. | Compositions for the treatment of inflammation of the gastrointestinal tract |
WO2011067667A2 (en) | 2009-12-02 | 2011-06-09 | Eurand Pharmaceuticals Limited | Fexofenadine microcapsules and compositions containing them |
-
1992
- 1992-05-21 CA CA002069162A patent/CA2069162A1/en not_active Abandoned
- 1992-05-21 TW TW081103962A patent/TW202387B/zh active
- 1992-05-21 EP EP92304634A patent/EP0516345A1/en not_active Withdrawn
- 1992-05-22 NO NO92922019A patent/NO922019L/no unknown
- 1992-05-22 ZA ZA923711A patent/ZA923711B/xx unknown
- 1992-05-26 KR KR1019920008916A patent/KR920021144A/ko not_active Application Discontinuation
- 1992-05-26 HU HU9201751A patent/HU9201751D0/hu unknown
- 1992-05-27 JP JP4134856A patent/JPH05148142A/ja not_active Withdrawn
- 1992-05-27 MX MX9202507A patent/MX9202507A/es unknown
- 1992-05-27 AU AU17218/92A patent/AU1721892A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
NO922019D0 (no) | 1992-05-22 |
ZA923711B (en) | 1993-11-22 |
EP0516345A1 (en) | 1992-12-02 |
KR920021144A (ko) | 1992-12-18 |
HU9201751D0 (en) | 1992-08-28 |
NO922019L (no) | 1992-11-30 |
AU1721892A (en) | 1992-12-03 |
JPH05148142A (ja) | 1993-06-15 |
TW202387B (es) | 1993-03-21 |
CA2069162A1 (en) | 1992-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE03108B1 (et) | Farmatseutiline kompositsioon | |
FI981777A0 (fi) | Farmaseuttinen ainekoostumus | |
FI925615A0 (fi) | Stabiliserade farmaceutiska kompositioner, som innehaoller en hmg-coa-reduktas-inhibitorfoerening | |
MX9204229A (es) | Trifluorometilbencilfosfonatos utiles en el tratamiento de osteoporosis. | |
MX9204625A (es) | Composicion farmaceutica para el tratamiento de una especie de mamifero, que sufre de deficiencia cardiaca congestiva. | |
FI921060A0 (fi) | Farmaceutiska aerosolformuleringar. | |
FI922316A0 (fi) | Farmaceutisk sammansaettning. | |
NL194664B (nl) | Farmaceutische samenstelling voor het genezen van tumorachtige ziekten. | |
FI901102A0 (fi) | Farmaceutiska kompositioner. | |
FI923581A0 (fi) | Farmaceutisk kombinationsformation. | |
MX9207008A (es) | Medicamentos para el tratamiento de condiciones inflamatorias o para la analgesia. | |
MX9200622A (es) | Composicion farmaceutica | |
NO911429L (no) | Stoffbehandling. | |
MX9202507A (es) | Composicion farmaceutica para el tratamiento de esofagitis de reflujo. | |
MX9205637A (es) | Metodo para prevenir el rechazo de aloinjertos. | |
BR9806083A (pt) | Composi-Æo farmac-utica para o tratamento da hapattite c | |
NO911430L (no) | Stoffbehandlingsmetode. | |
MX9201258A (es) | Compuestos para el tratamiento del cancer y procedimiento para su preparacion. | |
MX9204286A (es) | Agentes para el tratamiento de semillas. | |
MX9203208A (es) | Composicion farmaceutica y metodo para el tratamiento de trastornos digestivos. | |
FI920845A0 (fi) | Farmaceutiska kompositioner innehaollande interleukin-2. | |
ES2019583B3 (es) | Composicion para el tratamiento de infecciones. | |
MX9204485A (es) | Composicion farmaceutica para el tratamiento de enfermedades inflamatorias. | |
ES1017890Y (es) | Dispositivo para el tratamiento de uneros. | |
MX9203089A (es) | Composicion para el tratamiento de esquisofrenia. |